Casebase- powered by Alexander Thamm GmbH - black
Book your Demo
Data & AI Use Cases in Operations

AI-Powered Drug Discovery with Generative AI

Use Case Use Case Family: GenAI
Business Domain Business Domain: R&D
Process Processes: Drug Discovery and Preclinical Research
Challenge:

Traditional drug discovery is time-intensive, expensive, and prone to inaccurate predictions. Identifying effective compounds using standard methods often delays innovation and elevates risks in clinical phases.

Solution:

Generative AI enables fast and accurate simulation of novel compounds with therapeutic potential. By learning from molecular data, it proposes new structures similar to known drugs, accelerating discovery while cutting costs and lab time.

Benefits:

  • Accelerates drug candidate discovery

  • Reduces development costs and trial redundancies

  • Improves accuracy of efficacy and safety predictions

Target Group Target Group:
Pharma R&D Directors Biotech Innovation Managers Research Teams
Potential Industries Potential Industries:
Pharmaceuticals Biotechnology Healthcare
Limited Risk
Limited Risk systems Art. 50
with Transparency Obligations according Art. 50 EU AI Act
Disclaimer The information provided regarding the risk assessment is without guarantee. The complete classification of a use case according to the EU AI Act depends on numerous regulatory and company-specific factors. Therefore, the risk assessment is always case-specific. The risk assessment logic of Casebase is used for this purpose.